Precision genome engineering: from laboratory to clinic

Active Project Grant Awarded Last action

Award ID
R13TR006439
Recipient
Awarding agency
Obligated
$22,350

Award facts

Assistance listing
93.350 National Center for Advancing Translational Sciences
Completion date 17% complete
Place of performance
Silverthorne, CO, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Abstract
Support is requested for a keystone symposia conference entitled precision genome engineering: from laboratory to clinic, organized by DRS. Erik j. Sontheimer and leonela amoasii, with scientific programming input from keystone symposia. The meeting will take place january 25-28, 2027 at keystone resort in keystone, CO. The keystone symposia conference on precision genome engineering: from laboratory to clinic will highlight transformative advances that are reshaping the future of genetic medicine by pushing the boundaries of what is possible with genome editing technologies. As the field evolves from proof-of-concept to therapeutic application, critical questions around efficiency, specificity, safety, delivery, and scalability of gene editing technologies remain. This conference will address these gaps by convening world leaders and emerging innovators to explore next-generation tools, delivery strategies, integrative technologies, and clinical findings that are redefining genome engineering. The program is designed to showcase cutting-edge research while fostering cross- disciplinary dialogue and collaboration. Attendees will engage in sessions covering innovation in editing systems, viral and non-viral delivery approaches, safety and specificity assessments, and the convergence of genome biology with artificial intelligence. These outcomes will be further advanced by the concurrent keystone symposia conference on tissue-specific delivery of genetic medicines. Keynote addresses and joint sessions will emphasize in vivo applications and translational readiness, providing a comprehensive view of the field's trajectory. The meeting will bring together genome engineers, molecular biologists, delivery experts, AI scientists, and translational researchers-providing a dynamic platform to exchange ideas, form new collaborations, and stay at the forefront of scientific and technological innovation. What sets this symposium apart from other conferences on crispr technologies or nucleic acid therapeutics is its deep focus on the precision and evolution of genome editing itself, ranging from mechanistic insights to therapeutic design, paired with timely discussions on how AI and delivery systems are accelerating discovery. Attendees will leave with an overview of where the field is headed and how to contribute to its next breakthroughs.

Quick answers

Who received award R13TR006439?

R13TR006439 was awarded to Keystone Symposia On Molecular And Cellular Biology by National Center for Advancing Translational Sciences (National Institutes of Health) on August 19, 2026.

How much is award R13TR006439 worth?

$22,350 has been obligated on R13TR006439.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login